drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy

Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Week of   

Week of Mon, May 27th, 2013

Clear Eyes signs Vanessa Williams as spokeswoman

Actress and singer Vanessa Williams has joined Clear Eyes as its new brand spokeswoman.

Gatorade teams with NFL, MLS to prevent heat illness

The Gatorade Co. has partnered with the National Football League (NFL) and Major League Soccer (MLS) for the "Gatorade Beat the Heat" educational campaign.

GUM Crayola launches colorful toothpaste for kids

Sunstar Americas Inc. has added GUM Crayola Squeeze-A-Color Toothpaste to its lineup of children's oral care products.

Mondelez enters 'mobile-only' marketing pact with Google

Mondelez International Inc. has signed a sweeping strategic agreement with Google to boost its global mobile marketing.

South Beach Diet introduces new snack bars

South Beach Diet has expanded its line nutritious snacks with two new snack bars.

Endo Health COO, CFO leaving company

Endo Health Solutions Inc. has announced the departure of Julie McHugh, chief operating officer, and Alan Levin, executive vice president and chief financial officer.

Mylan Specialty, pro baseball raise awareness of anaphylaxis

Mylan Specialty L.P. is partnering with a roster of pro baseball teams to host Allergy Awareness games at select stadiums across the country.

Perrigo releases Sanctura XR generic

Perrigo Co. has received final approval for trospium chloride extended-release capsules (60 mg), a medication for overactive bladder.

Prestige Brands enlists TABS Group promotion analytics

TABS Group Inc. has entered an agreement to provide promotion optimization services to over-the-counter health products company Prestige Brands Inc.

Cracker Jack adds new varieties, updates prizes

Cracker Jack has introduced two new flavors, added more peanuts and "modernized" the prizes for its iconic caramel corn snack.

AstraZeneca to acquire specialty drug maker Omthera

AstraZeneca plans to buy Omthera Pharmaceuticals, a Princeton, N.J.-based specialty pharmaceutical company focused on medications for dyslipidemia.

Valeant to buy Bausch+Lomb for $8.7 billion

Valeant Pharmaceuticals International Inc. is acquiring Bausch+Lomb Holdings Inc. for $8.7 billion in cash.